Carboplatin and Type i hypersensitivity - a phase IV clinical study of FDA data
Summary:
Type i hypersensitivity is reported as a side effect among people who take Carboplatin (carboplatin), especially for people who are female, 50-59 old, have been taking the drug for < 1 month also take Gemcitabine, and have Ovarian cancer.
The phase IV clinical study analyzes which people have Type i hypersensitivity when taking Carboplatin. It is created by eHealthMe based on reports of 127,949 people who have side effects when taking Carboplatin from the FDA, and is updated regularly.
What is Carboplatin?
Carboplatin has active ingredients of carboplatin. It is often used in cancer. eHealthMe is studying from 128,210 Carboplatin users. Check the latest studies of Carboplatin.
What is Type i hypersensitivity?
Type i hypersensitivity is found to be associated with 134 drugs and 308 conditions by eHealthMe. Check the latest studies of Type i hypersensitivity.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
127,949 people reported to have side effects when taking Carboplatin.
Among them, 106 people (0.08%) have Type i hypersensitivity.
Among these 106 people:
How long have people been on Carboplatin when they have Type i hypersensitivity? *
What is the gender of people who have Type i hypersensitivity when taking Carboplatin? *
What is the age of people who have Type i hypersensitivity when taking Carboplatin? *
What are other drugs people take besides Carboplatin? *
What are other side effects people have besides Type i hypersensitivity? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Carboplatin and have Type i hypersensitivity?
- Check whether Type i hypersensitivity is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Carboplatin:
- Carboplatin (128,210 reports)
Type i hypersensitivity treatments and more:
- Type i hypersensitivity (2,978 reports)
How severe was Type i hypersensitivity and when was it recovered:
Expand to all the drugs that have ingredients of carboplatin:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Carboplatin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Type i hypersensitivity:
- Type i hypersensitivity (134 drugs)
Browse all the conditions that are associated with Type i hypersensitivity:
- Type i hypersensitivity (308 conditions)
Related publications that referenced our studies
- Zakaria S, Lu KY, Nussenblatt V, Browner I, "Atrial flutter associated with carboplatin administration", Annals of Pharmacotherapy, 2011 Nov .
- Zakaria S, Lu KY, Nussenblatt V, Browner I, "Atrial flutter associated with carboplatin administration", Annals of Pharmacotherapy, 2011 Nov .
How the study uses the data?
The study uses data from the FDA. It is based on carboplatin (the active ingredients of Carboplatin) and Carboplatin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Colace and Protruding Eyes for Women aged 40-49 - a second ago
- Colace and Proptosis for Women aged 40-49 - a second ago
- Colace and Exophthalmos for Women aged 40-49 - a second ago
- Colace and Bulging Eyes for Women aged 40-49 - 2 seconds ago
- Colace and Eyes - Bulging for Women aged 40-49 - 2 seconds ago
- Drug interactions of Carboplatin and Movicol - 7 seconds ago
- Could Dexamethasone cause Catheter Thrombosis? - 10 seconds ago
- Could Dexamethasone cause Soft Tissue Injury? - 10 seconds ago
- Endep vs. Adderall 30, side effect and effectiveness comparison - 19 seconds ago
- Rhinocort and Throat Irritation for Women aged 40-49 - 34 seconds ago